Zealand Pharma A/S
GIP-GLP-1 dual agonist compounds and methods
Last updated:
Abstract:
The present invention relates to acylated GIP analogues which have dual GIP and GLP-1 activity, and their use in the treatment of metabolic disorders.
Status:
Grant
Type:
Utility
Filling date:
27 Aug 2018
Issue date:
18 May 2021